Business Context and Reporting Period
Company: TherapeuticsMD, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 12, 2019
Context: The filing serves as a Regulation FD disclosure to furnish an investor presentation (Exhibit 99.1) intended for use in meetings with investors or analysts. The document explicitly states that the information is not "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report acts as a cover for an attached presentation rather than a financial statement itself.
Material Changes
No material changes to financial performance or operations are detailed within the text of this specific Form 8-K. The filing solely announces the availability of the investor presentation.
Guidance, Outlook, and Risks
Management Commentary: The company is providing an investor presentation dated March 2019 for use in investor relations activities.
Legal Disclaimer: The information furnished is not deemed incorporated by reference into any other filings under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as expressly set forth by specific reference.
Risks: No specific risks or contingencies are enumerated in the body of this filing.
Investor Verification Checklist
- Review Exhibit 99.1 (TherapeuticsMD, Inc. presentation dated March 2019) for actual financial data and strategic outlook.
- Verify if the presentation contains forward-looking statements that differ from previously filed 10-K or 10-Q reports.
- Confirm the date of the investor presentation to ensure it aligns with the March 12, 2019 reporting date.
- Note that this 8-K does not constitute a formal filing of financial results under Section 18 of the Exchange Act.